Search Results

37 - 40 of 40 Products for '405 nm laser' Page 4 of 4 |

405 nm laser

Bio Photonics - April 2015

Bio Photonics - April 2015


lasers at 588 and 594 nm were recently
introduced for exciting orange fluorophores. Other models at 550 nm have also
been developed, as this wavelength can
be used to excite green dyes and several
new yellow fluorophores simultaneously
with a single laser. Yet another…

Bio Photonics - September 2015

Bio Photonics - September 2015

…In 2014, the lab acquired several digitally modulatable smart lasers to enable
multiwavelength TIRF microscopy. These
lasers included Coherent's fiber-pigtailed
OBIS FP modules that operate at 488,
561 and 640 nm. The lab also acquired
the OBIS Galaxy, which enables simple…

LIT BioPhotonics OBIS-GALAXY TIRF-Microscopy 0915.pdf

LIT BioPhotonics OBIS-GALAXY TIRF-Microscopy 0915.pdf

…In 2014, the lab acquired several digitally modulatable smart lasers to enable
multiwavelength TIRF microscopy. These
lasers included Coherent's fiber-pigtailed
OBIS FP modules that operate at 488,
561 and 640 nm. The lab also acquired
the OBIS Galaxy, which enables simple…

eLP11-02-56  Coherent

eLP11-02-56 Coherent

…of analyzers.
These lasers deliver a few tens of milliwatts, and are available at several visible wavelengths which match the optimum excitation of common fluorescent
probes and genetically encoded markers
(typically 405, 450, 488, 520 and
640 nm). These products are based on…

Powered by Site Search powered by SLI Systems

Please Read Before Continuing

Risk factors: Except for the historical information contained here, many of the matters discussed in this Web site are forward-looking statements, based on expectations at the time they were made, that involve risks and uncertainties that could cause our results to differ materially from those expressed or implied by such statements. These risks are detailed in the “Factors That May Affect Future Results” section of our latest 10-K or 10-Q filing. Coherent assumes no obligation to update these forward-looking statements.


I have read the terms and conditions